Laurion Capital Management »

Adagio Therapeutics shares owned by Laurion Capital Management

Quarter-by-quarter ownership of Adagio Therapeutics (IVVD) shares owned by Laurion Capital Management from 13F filings

Historical chart of Laurion Capital Management investment in Adagio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Adagio Therapeutics held by Laurion Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Adagio Therapeutics by Laurion Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $63k 16k 3.94

More positions owned by Laurion Capital Management

Ishares Tr Iboxx Hi Yd Etf (HYG)
Meta Platforms Cl A Call Option (META)
Apple (AAPL)
Tesla Motors Call Option (TSLA)
Kenvue (KVUE)
Microsoft Corporation Call Option (MSFT)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Alibaba Group Hldg Sponsored Ads Call Option (BABA)
Adobe Systems Incorporated Call Option (ADBE)
Alphabet Cap Stk Cl C Call Option (GOOG)
Bridgebio Pharma (BBIO)
NVIDIA Corporation Call Option (NVDA)
Bank of America Corporation (BAC)
Alphabet Cap Stk Cl A Call Option (GOOGL)
Intel Corporation Call Option (INTC)

View all positions for Laurion Capital Management

Top funds holding Adagio Therapeutics

Maverick Capital
M28 Capital Management
Alphabet
OrbiMed Advisors
683 Capital Management
Vanguard Group
Redmile Group
Millennium Management
Jacobs Levy Equity Management
Charles Schwab Investment Management
Citigroup
Acuitas Investments
Jane Street
Squarepoint Ops
Balyasny Asset Management

View all funds holding Adagio Therapeutics